SARS-CoV-2 ORF7a anticorps (C-Term)

N° du produit ABIN6992305

Détail du produit anti-SARS-CoV-2 ORF7a anticorps

Antigène: SARS-CoV-2 ORF7a

Épitope: C-Term

Reactivité: SARS Coronavirus-2 (SARS-CoV-2)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SARS-CoV-2 ORF7a est non-conjugé

Application: ELISA

Purification: SARS-CoV-2 (COVID-19) ORF7a Antibody is affinity chromatography purified via peptide column.

Immunogène: Anti-SARS-CoV-2 (COVID-19) ORF7a antibody was raised against a peptide corresponding to 9 amino acids near the carboxyl terminus of SARS-CoV-2 (COVID-19) ORF7a protein. The immunogen is located within the last 50 amino acids of the SARS-CoV-2 (COVID-19) ORF7a protein.

Isotype: IgG

Information d'application

Indications d'application: Antibody validated: SARS-CoV-2 (COVID-19) ORF7a antibody can detect 2 ng of free peptide at 1 μ,g/mL in ELISA. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: SARS-CoV-2 (COVID-19) ORF7a antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: SARS-CoV-2 (COVID-19) ORF7a antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur SARS-CoV-2 ORF7a

Antigène: SARS-CoV-2 ORF7a

Abstract: SARS-CoV-2 ORF7a Produits

Synonymes: anticorps ORF7a protein, anticorps ORF7a

Classe de substances: Viral Protein

Sujet: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019-20 coronavirus outbreak (2). SARS-CoV-2 virus proteins include structural proteins, non-structural proteins and accessory factors. The structure of SARS-CoV-2 consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. SARS-CoV-2 non-structural protein is ORF1ab that consists of 16 proteins (nsp1-nsp16), while accessory factors include ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8, ORF9b, ORF7a and ORF7a. ORF7a plays a role as antagonist of host tetherin (BST2), disrupting its antiviral effect. It acts by binding to BST2 thereby interfering with its glycosylation. It may suppress small interfering RNA (siRNA) and may bind to host ITGAL, thereby playing a role in attachment or modulation of leukocytes (3).

Poids moléculaire: 14kD kDa

ID gène: 43740573

UniProt: P0DTC7